These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 17887744)

  • 1. QSAR modeling using automatically updating correction libraries: application to a human plasma protein binding model.
    Rodgers SL; Davis AM; Tomkinson NP; van de Waterbeemd H
    J Chem Inf Model; 2007; 47(6):2401-7. PubMed ID: 17887744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma protein binding affinity and its relationship to molecular structure: an in-silico analysis.
    Gleeson MP
    J Med Chem; 2007 Jan; 50(1):101-12. PubMed ID: 17201414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The importance of the domain of applicability in QSAR modeling.
    Weaver S; Gleeson MP
    J Mol Graph Model; 2008 Jun; 26(8):1315-26. PubMed ID: 18328754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Critical assessment of QSAR models of environmental toxicity against Tetrahymena pyriformis: focusing on applicability domain and overfitting by variable selection.
    Tetko IV; Sushko I; Pandey AK; Zhu H; Tropsha A; Papa E; Oberg T; Todeschini R; Fourches D; Varnek A
    J Chem Inf Model; 2008 Sep; 48(9):1733-46. PubMed ID: 18729318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unified QSAR approach to antimicrobials. Part 3: first multi-tasking QSAR model for input-coded prediction, structural back-projection, and complex networks clustering of antiprotozoal compounds.
    Prado-Prado FJ; González-Díaz H; de la Vega OM; Ubeira FM; Chou KC
    Bioorg Med Chem; 2008 Jun; 16(11):5871-80. PubMed ID: 18485714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. QSAR models for predicting the similarity in binding profiles for pairs of protein kinases and the variation of models between experimental data sets.
    Sheridan RP; Nam K; Maiorov VN; McMasters DR; Cornell WD
    J Chem Inf Model; 2009 Aug; 49(8):1974-85. PubMed ID: 19639957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined 3D-QSAR modeling and molecular docking study on indolinone derivatives as inhibitors of 3-phosphoinositide-dependent protein kinase-1.
    AbdulHameed MD; Hamza A; Liu J; Zhan CG
    J Chem Inf Model; 2008 Sep; 48(9):1760-72. PubMed ID: 18717540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. logD7.4 modeling using Bayesian Regularized Neural Networks. Assessment and correction of the errors of prediction.
    Bruneau P; McElroy NR
    J Chem Inf Model; 2006; 46(3):1379-87. PubMed ID: 16711757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combinatorial QSAR modeling of chemical toxicants tested against Tetrahymena pyriformis.
    Zhu H; Tropsha A; Fourches D; Varnek A; Papa E; Gramatica P; Oberg T; Dao P; Cherkasov A; Tetko IV
    J Chem Inf Model; 2008 Apr; 48(4):766-84. PubMed ID: 18311912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Linear and nonlinear 3D-QSAR approaches in tandem with ligand-based homology modeling as a computational strategy to depict the pyrazolo-triazolo-pyrimidine antagonists binding site of the human adenosine A2A receptor.
    Michielan L; Bacilieri M; Schiesaro A; Bolcato C; Pastorin G; Spalluto G; Cacciari B; Klotz KN; Kaseda C; Moro S
    J Chem Inf Model; 2008 Feb; 48(2):350-63. PubMed ID: 18215030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of human pharmacokinetics--evaluation of methods for prediction of volume of distribution.
    Fagerholm U
    J Pharm Pharmacol; 2007 Sep; 59(9):1181-90. PubMed ID: 17883888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MMM-QSAR recognition of ribonucleases without alignment: comparison with an HMM model and isolation from Schizosaccharomyces pombe, prediction, and experimental assay of a new sequence.
    Agüero-Chapín G; Gonzalez-Díaz H; de la Riva G; Rodríguez E; Sanchez-Rodríguez A; Podda G; Vazquez-Padrón RI
    J Chem Inf Model; 2008 Feb; 48(2):434-48. PubMed ID: 18254616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predicting plasma protein binding of drugs--revisited.
    Kratochwil NA; Huber W; Müller F; Kansy M; Gerber PR
    Curr Opin Drug Discov Devel; 2004 Jul; 7(4):507-12. PubMed ID: 15338960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative structure-activity relationship (QSAR) modeling of human blood: air partitioning with proper statistical methods and validation.
    Basak SC; Mills D; Hawkins DM; Kraker JJ
    Chem Biodivers; 2009 Apr; 6(4):487-502. PubMed ID: 19353545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combinatorial QSAR modeling of specificity and subtype selectivity of ligands binding to serotonin receptors 5HT1E and 5HT1F.
    Wang XS; Tang H; Golbraikh A; Tropsha A
    J Chem Inf Model; 2008 May; 48(5):997-1013. PubMed ID: 18470978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unified QSAR approach to antimicrobials. 4. Multi-target QSAR modeling and comparative multi-distance study of the giant components of antiviral drug-drug complex networks.
    Prado-Prado FJ; Martinez de la Vega O; Uriarte E; Ubeira FM; Chou KC; González-Díaz H
    Bioorg Med Chem; 2009 Jan; 17(2):569-75. PubMed ID: 19112024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A group center overlap based approach for "3D QSAR" studies on TIBO derivatives.
    Sapre NS; Gupta S; Pancholi N; Sapre N
    J Comput Chem; 2009 Apr; 30(6):922-33. PubMed ID: 18785154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel method for protein-ligand binding affinity prediction and the related descriptors exploration.
    Li S; Xi L; Wang C; Li J; Lei B; Liu H; Yao X
    J Comput Chem; 2009 Apr; 30(6):900-9. PubMed ID: 18785151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-based approach to pharmacophore identification, in silico screening, and three-dimensional quantitative structure-activity relationship studies for inhibitors of Trypanosoma cruzi dihydrofolate reductase function.
    Schormann N; Senkovich O; Walker K; Wright DL; Anderson AC; Rosowsky A; Ananthan S; Shinkre B; Velu S; Chattopadhyay D
    Proteins; 2008 Dec; 73(4):889-901. PubMed ID: 18536013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinetic determinants of hepatic clearance: plasma protein binding and hepatic uptake.
    Baker M; Parton T
    Xenobiotica; 2007; 37(10-11):1110-34. PubMed ID: 17968739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.